AlphaValue Corporate Services has been commissioned and paid for by the covered companies and is deemed to constitute an acceptable minor non-monetary benefit as defined in MiFID II.

 

RESEARCH PUBLICATIONS

BY COMPANIES BY SECTORS BY YEAR

 



COUNTRY SECTOR INDUSTRY MARKET CAP.
CNTY France Med Tech Health €26m
DESCRIPTION
Incorporated in 1999, Ikonisys is a diagnostic firm developing instruments and software for oncology/ cancer and prenatal testing/ applications. It operates in the highly concentrated c.$69bn global in-vitro diagnostic (IVD) market (dominated by heavyweights like Roche Diagnostics, Abbot Laboratories and Siemens) and is trying to establish its niche in the two segments of the market – FISH (fluorescence in situ hybridisation; market size: $1.2bn) and CTC (circulating tumour cells; market size: $0.5bn).

DATE PUBLICATION VIEW FULL REPORT
Nov 8th, 2021 Soft H1, but on track to achieve mid-term targets View Download
Oct 22nd, 2021 Factoring in the revised commercialisation plans View Download
Jul 20th, 2021 A ‘fully-automated’ oncology diagnostic play View Download